Healthcare-specific foundation model and AI agent platform delivering low-acuity clinical conversations for hospitals and payers
Hippocratic AI builds a healthcare-specific foundation model (Polaris) for low-acuity patient-facing conversations like care coordination, dietitian consultations, and medication reminders. Founded by Munjal Shah (serial entrepreneur, ex-Like.com → Google acquisition). Tested with 5,500+ licensed nurses for safety validation. Partnered with NVIDIA on optimized inference. Customers include WellSpan Health, Cincinnati Children's, and Universal Health Services.
Healthcare📍 Palo Alto, CAFounded 2023
Current Valuation
$3.5B
as of 2025-Q1
UNICORN
QL Price
$3.5B
0% vs last round
QuantLogix's current estimate for Hippocratic AI, published 2026-10-08 — in line with the last disclosed round of $3.5B (2025-11).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$3.5B
2025-11
weight 0.52
Secondary market print
$3.5B
2026-06-27
weight 0.54
How this price has held up
No round has priced for Hippocratic AI since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-10-08 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Hippocratic AI, 2026-10-08 (90f1ad2c8125b882).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Hippocratic AI going public?
No. Hippocratic AI has no imminent IPO plans on record. It is still private.
What is Hippocratic AI's valuation in 2026?
Hippocratic AI is valued at $3.5B as of 2025-Q1, set by its Series B ($141M, Jan 2025). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Hippocratic AI filed an S-1?
No public S-1 is on file for Hippocratic AI.
Who are Hippocratic AI's investors?
Hippocratic AI's investors include Kleiner Perkins, Andreessen Horowitz, Premji Invest, General Catalyst, NVIDIA, Universal Health Services.
How much has Hippocratic AI raised?
Hippocratic AI has raised $278M in total, most recently a Series B of $141M in Jan 2025.
Is Hippocratic AI publicly traded — can you buy Hippocratic AI stock?
No. Hippocratic AI is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Hippocratic AI on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
CEO
Munjal Shah
Founded
2023
HQ
Palo Alto, CA
Employees
~250
Total Raised
$278M
Growth
Early commercial (health system pilots)
Last Round
Series B — $141M (Jan 2025) · Lead: Kleiner Perkins
IPO Status
no imminent plans
Fundraising Status
Series B · $141M · 1y 9mo ago
no imminent plansTotal raised $278M
Secondary Market
Implied price / share
$26.33
Last round price / share
$26.33
vs last round
0.0%
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series B
$141M
Jan 2025
Kleiner Perkins
—
Vertical Intelligence — AI / ML
Open models
0
Downloads (30d)
0
across all models
Followers
16
Attributed to Hugging Face organization "Hippocratic AI" as of 2026-10-04. Open-weights footprint only — closed-model usage is not publicly measurable. Verify on Hugging Face ↗
Talent Signal
Hiring trend
▲ Hiring uptrend
+340% vs 2026-08
Open roles
22
via careers page
Product-build share
55%
engineering, research, product, design
Trajectory
expanding
product-led hiring — 55% of open roles build product; the rest are go-to-market and G&A.
No tracked executive churn; open roles trending up.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
LLM ResearchClinical ResearchNurse GrantsNurse Co-PilotAI Physician Front DoorAI Pharmacy
Counted from Hippocratic AI's live job board as of 2026-09-15; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Founders & Key People
Munjal Shah
Investors
Kleiner Perkins · Andreessen Horowitz · Premji Invest · General Catalyst · NVIDIA · Universal Health Services
Products
Hippocratic Healthcare LLM
Polaris (constellation of healthcare agents)
Pulse (medical history-taking agent)
Competitors
Suki AI · Abridge · Ambience Healthcare · DeepScribe · Glass Health
HealthcareAIClinical AIHealthcare LLM
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2025-Q1. Refreshed quarterly.